Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes

Thrombosis Research

Volumn 132, Issue 6, 2013, Pages 770-775

  Witt, Daniel M ^a,b   Delate, Thomas ^a,b   Hylek, Elaine M ^c   Clark, Nathan P ^a,b   Crowther, Mark A ^d   Dentali, Francesco ^e   Ageno, Walter ^e   Martinez, Kerri D ^a   Garcia, David A ^f  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF INSUBRIA   (Italy)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Anticoagulants; Emergency Treatment; Intracerebral Hemorrhages; Risk Factors; Stroke; Warfarin

Indexed keywords

FRESH FROZEN PLASMA; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; VITAMIN K GROUP; WARFARIN;

AGED; ALCOHOLISM; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING DISORDER; BRAIN HEMORRHAGE; CARDIOMYOPATHY; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FATALITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VALVE PROSTHESIS; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; CDS; CHRONIC DISEASE SCORE; CI; CLINICAL PHARMACY ANTICOAGULATION AND ANEMIA SERVICE; CONFIDENCE INTERVAL; CPAAS; EMERGENCY TREATMENT; HAZARD RATIO; HR; ICD-9; ICH; INR; INTERNATIONAL CLASSIFICATION OF DISEASES, NINTH EDITION; INTERNATIONAL NORMALIZED RATIO; INTRACEREBRAL HEMORRHAGES; INTRACRANIAL HEMORRHAGE; KAISER PERMANENTE COLORADO; KPCO; RISK FACTORS; STROKE; WARFARIN;

AGED; ANTICOAGULANTS; COHORT STUDIES; COLORADO; FEMALE; HUMANS; INCIDENCE; INTRACRANIAL HEMORRHAGES; LOGISTIC MODELS; MALE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; WARFARIN;

EID: 84889886957     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.10.024     Document Type: Article

References (17)

1. W. Ageno, A.S. Gallus, A. Wittkowsky, M. Crowther, E.M. Hylek, and G. Palareti Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e44S e88S
2. R.G. Hart, B.S. Boop, and D.C. Anderson Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses Stroke 26 1995 1471 1477
3. E.M. Hylek, and D.E. Singer Risk factors for intracranial hemorrhage in outpatients taking warfarin Ann Intern Med 120 1994 897 902
4. M.L. Flaherty, B. Kissela, D. Woo, D. Kleindorfer, K. Alwell, and P. Sekar The increasing incidence of anticoagulant-associated intracerebral hemorrhage Neurology 68 2007 116 121
5. D.M. Witt, M.A. Sadler, R.L. Shanahan, G. Mazzoli, and D.J. Tillman Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy Chest 127 2005 1515 1522
6. F.R. Rosendaal, S.C. Cannegieter, F.J. van der Meer, and E. Briet A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemost 69 1993 236 239
7. D.O. Clark, K.M. Von, K. Saunders, W.M. Baluch, and G.E. Simon A chronic disease score with empirically derived weights Med Care 33 1995 783 795
8. M. VonKorff, E.H. Wagner, and K. Saunders A chronic disease score from automated pharmacy data J Clin Epidemiol 45 1992 197 203
9. A. Sjalander, G. Engstrom, E. Berntorp, and P. Svensson Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population J Intern Med 254 2003 434 438
10. J. Huhtakangas, S. Tetri, S. Juvela, P. Saloheimo, M.K. Bode, and M. Hillbom Effect of increased warfarin use on warfarin-related cerebral hemorrhage: a longitudinal population-based study Stroke 42 2011 2431 2435
11. A. Biffi, T.W. Battey, A.M. Ayres, L. Cortellini, K. Schwab, and A.J. Gilson Warfarin-related intraventricular hemorrhage: imaging and outcome Neurology 77 2011 1840 1846
12. N. Dequatre-Ponchelle, H. Henon, M. Pasquini, M.P. Rutgers, R. Bordet, and D. Leys Vitamin k antagonists-associated cerebral hemorrhages: what are their characteristics? Stroke 44 2013 350 355
13. M.L. Flaherty, H. Tao, M. Haverbusch, P. Sekar, D. Kleindorfer, and B. Kissela Warfarin use leads to larger intracerebral hematomas Neurology 71 2008 1084 1089
14. R.L. Jeffree, D.H. Gordon, R. Sivasubramaniam, and A. Chapman Warfarin related intracranial haemorrhage: a case-controlled study of anticoagulation monitoring prior to spontaneous subdural or intracerebral haemorrhage J Clin Neurosci 16 2009 882 885
15. J.N. Goldstein, S.H. Thomas, V. Frontiero, A. Joseph, C. Engel, and R. Snider Timing of fresh frozen plasma administration and rapid correction of coagulopathy in warfarin-related intracerebral hemorrhage Stroke 37 2006 151 155
16. A.Y. Zubkov, J.N. Mandrekar, D.O. Claassen, E.M. Manno, E.F. Wijdicks, and A.A. Rabinstein Predictors of outcome in warfarin-related intracerebral hemorrhage Arch Neurol 65 2008 1320 1325
17. K. Maeda, M. Koga, Y. Okada, K. Kimura, H. Yamagami, and S. Okuda Nationwide survey of neuro-specialists' opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation J Neurol Sci 312 2012 82 85